KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Arbutus Biopharma (ABUS) Preferred Dividend Payments: 2017-2021

Historic Preferred Dividend Payments for Arbutus Biopharma (ABUS) over the last 4 years, with Dec 2021 value amounting to $574,000.

  • Arbutus Biopharma's Preferred Dividend Payments fell 81.62% to $574,000 in Q4 2021 from the same period last year, while for Dec 2021 it was $12.1 million, marking a year-over-year increase of 0.13%. This contributed to the annual value of $12.1 million for FY2021, which is 0.13% up from last year.
  • Latest data reveals that Arbutus Biopharma reported Preferred Dividend Payments of $574,000 as of Q4 2021, which was down 88.72% from $5.1 million recorded in Q3 2021.
  • Over the past 5 years, Arbutus Biopharma's Preferred Dividend Payments peaked at $5.1 million during Q3 2021, and registered a low of $574,000 during Q4 2021.
  • Its 3-year average for Preferred Dividend Payments is $3.0 million, with a median of $3.0 million in 2020.
  • As far as peak fluctuations go, Arbutus Biopharma's Preferred Dividend Payments spiked by 190.56% in 2018, and later slumped by 81.62% in 2021.
  • Over the past 5 years, Arbutus Biopharma's Preferred Dividend Payments (Quarterly) stood at $911,000 in 2017, then skyrocketed by 190.56% to $2.6 million in 2018, then increased by 8.80% to $2.9 million in 2019, then climbed by 8.44% to $3.1 million in 2020, then tumbled by 81.62% to $574,000 in 2021.
  • Its Preferred Dividend Payments was $574,000 in Q4 2021, compared to $5.1 million in Q3 2021 and $3.3 million in Q2 2021.